3-5
2026
影响因子区间
—
平台估算
5%
2025
中国作者发文占比
2650 USD
收费
期刊简介:The journal brings readers the latest developments in the fast moving field of cellular therapy in man. This includes cell therapy for cancer, immune disorders, inherited diseases, tissue repair and regenerative medicine. The journal covers the science, translational development and treatment with variety of cell types including hematopoietic stem cells, immune cells (dendritic cells, NK, cells, T cells, antigen presenting cells) mesenchymal stromal cells, adipose cells, nerve, muscle, vascular and endothelial cells, and induced pluripotential stem cells. We also welcome manuscripts on subcellular derivatives such as exosomes. A specific focus is on translational research that brings cell therapy to the clinic. Cytotherapy publishes original papers, reviews, position papers editorials, commentaries and letters to the editor. We welcome "Protocols in Cytotherapy" bringing standard operating procedure for production specific cell types for clinical use within the reach of the readership.
【译文】该期刊为读者带来了人类细胞治疗领域快速发展的最新进展。这包括癌症、免疫疾病、遗传疾病、组织修复和再生医学的细胞治疗。该期刊涵盖了包括造血干细胞、免疫细胞(树突状细胞、NK细胞、T细胞、抗原呈递细胞)、间充质干细胞、脂肪细胞、神经、肌肉、血管和内皮细胞以及诱导多能干细胞在内的各种细胞类型的科学、转化发展和治疗。我们欢迎关于亚细胞衍生物,如外泌体的稿件。特别关注的是将细胞治疗带入临床的转化研究。Cytotherapy发表原创论文、综述、立场论文、社论、评论和编者来信。我们欢迎发表“细胞治疗协议”,为读者提供生产特定细胞类型用于临床使用的标准操作程序。

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q1 | 暂无 |
| 中科院分区 | 3区 | 暂无 |
| 影响因子区间 | 3-5 | 暂无 |